Shrieve Chemical Company
Overview
| Deal Type |
Mergers & Acquisitions Corporate Banking |
|---|---|
| Client & Transactional Partners |
Shrieve Chemical Company Gemspring Capital |
Our Role | Exclusive Sell-Side Advisor |
Summary
On December 2, 2019, KeyBanc Capital Markets (“KBCM”) successfully completed the sale of a majority interest in Shrieve Chemical Company, LLC (“Shrieve”) to Gemspring Capital (“Gemspring”).
KBCM was chosen to serve as exclusive sell-side advisor based on its expertise within the industrial distribution and chemicals sectors, relationship with Shrieve and proven M&A execution capabilities.
